//
Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE